existing technology or device or by designing a device to serve a need that is clearly defined and acknowledged by medical professionals. Each product will be priced to appeal to a managed-care market that stresses lowest cost of total treatment parameters. Market segments are clearly defined and are all subject to a high growth trend. Plans for future development include additional technologies that will be developed and patented as appropriate by Erica Ross, VP of R&D for MedBlue. In addition, MedBlue may seek to acquire certain technologies developed by others once it attains sufficient capitalization. MedBlue's objective is to innovate and to market its products. Once an industry reputation has been achieved and marketing channels opened, expansion into other medical device areas becomes potentially rewarding. A recent article in Wired magazine indicates that the biotech field in general is a hotbed of activity with an exciting and lucrative future.